Parkinson disease (PD) is characterized by progressive degeneration of dopaminergic neurons of the nigrostriatal system and dopamine (DA) depletion in the striatum. While the pathogenesis of PD is not clear, damage of dopaminergic neurons by oxygen derived free radicals is considered to be an important contributing mechanism.
In this study, we examined the effects of eugenol on 6-OHDA-induced DA depletion in the mouse striatum, and on the activities of catalase and GPx as well as superoxide scavenging activity (SOSA) in the mouse striatum. We also examined the levels of antioxidants such as GSH and Asc, and the lipid peroxidation-inhibiting activity of eugenol.
MATERIALS AND METHODS

Effect of Eugenol on Oxidation of Mouse Brain Homogenate in Vitro
Mouse brains were homogenized in 10 volume of ice-cold Tris-HCl buffer (pH 7.6, 50 mM). After eugenol in 1% ethanol/saline solution (100 ml; final concentration: 0.1-1000 mM) and ferric chloride in Tris-HCl buffer solution (20 ml; final concentrations: 5 mM) was added to homogenate (100 ml), the mixture was incubated at 37°C for 20 min to induce oxidation. Lipid peroxides produced were monitored by measuring concentrations of thiobarbituric acid reactive substance (TBARS).
Effect of Eugenol on SOD-Like Activity of Mouse Brain Homogenate in Vitro
Mouse brains were homogenized with 10 volume of ice-cold phosphate buffer (pH 8.0, 10 mM) and centrifuged at 10000ϫg for 10 min at 4°C. After eugenol in 1% ethanol/saline solution (100 ml; final concentrations: 0.1-1000 mM) was added to the supernatants, SODlike activity of the mixture was measured using a SOD assay kit (SOD Test Wako: Wako Pure Chemical, Japan).
Animals Male ICR mice (Charles River, Japan Inc., Yokohama, Japan) weighing 30 to 35 g were used in all experiments. They were provided with water and standard laboratory diet containing 24% protein (MF; Oriental Yeast, Tokyo, Japan) ad libitum, and housed at 25°C with a 12-h light and 12-h dark cycle (7 a.m. to 7 p.m., lights on). New mice were used for every assay. The experimental protocol was approved by the Ethics Review Committee for the Ani- Health Sciences.
Effect of Treatment with Eugenol on Activity of Striatal Active Oxygen Scavenging Enzymes, Lipid Peroxidation Level, and GSH and Asp Levels in Mouse Striatum Eugenol was dissolved with ethanol and diluted with 99 volume of saline, and was injected subcutaneously at a dose of 1.0 or 0.1 mmol/kg body weight. The same volume of 1% ethanol/saline (5 ml/kg body weight) was injected as control. After 3 days' administration (once daily) of eugenol, mice were killed 30 min after the last administration under sodium pentobarbiturate anesthesia, and the striatum was removed on an ice plate and stored at Ϫ80°C until analysis.
Effect of Treatment with Eugenol against 6-OHDA Toxicity Eugenol was injected subcutaneously at a dose of 1.0 or 0.1 mmol/kg body weight. After 3 days' administration (once daily) of eugenol, 6-OHDA was injected into right lateral ventricle at a dose of 60 mg in 2 ml of saline 30 min after the last administration of eugenol. Two microliters of saline was injected as control. Eugenol was injected at the same dose once daily for 7 d after 6-OHDA injection. Seven days after 6-OHDA injection, mice were killed under sodium pentobarbiturate anesthesia and the right striatum was removed on an ice plate and stored at Ϫ80°C until analysis.
DA, 3,4-Dihydroxyphenylacetic Acid (DOPAC), and Homovanilic Acid (HVA) Levels Right striatal tissues were homogenized with 500 ml of 200 mM ice-cold perchloric acid containing 10 mM disodium EDTA. After centrifugation (10000ϫg for 10 min at 4°C), the supernatant was filtered (pore size, 0.45 mm) and then injected directly into a HPLC (Shimadzu, Kyoto, Japan) with an electrochemical detector (ECD; Eicom, Kyoto, Japan). The appendant potential of the ECD (carbon electrode vs. Ag/AgCl reference electrode) was set at 700 mV. The analytic column was TSKgel Super-ODS (4.6 mm I.D.ϫ100 mm; Tosoh, Tokyo, Japan), and the mobile phase consisted of 0.1 M citrate-sodium acetate buffer (pH 3.9) containing methanol (18%, v/v), disodium EDTA (4 mg/l), and sodium octanesulfonate (0.8 mM).
Superoxide Scavenging Activity (SOSA) SOSA was assayed by measuring · O 2 Ϫ using electron spin resonance (ESR) spectrometry of 5,5Ј-dimethyl-1-pyrroline N-oxide (DMPO)-O 2 Ϫ adducts after the · O 2 Ϫ produced in the hypoxanthine (HPX)/ xanthine oxidase (XOD) system was trapped by DMPO. Striatal tissues were homogenized with 10 volumes of ice-cold phosphate buffer (10 mM, pH 8.0) and centrifuged at 12000ϫg for 10 min at 4°C. A mixture of 50 ml of 2.0 mM HPX, 35 ml of 11 mM diethylenetriaminepentaacetic acid (DETAPAC), 50 ml of sample (supernatant after homogenate centrifugation, or serum), 20 ml of DMPO-water solution (DMPO : water, 1 : 1), and 50 ml of XOD was freshly prepared and transferred to the ESR spectrometry cell. DMPO-O 2 Ϫ spin adducts was quantified 60 s after addition of XOD. The signal intensities were evaluated by the peak height of the first signal of the DMPO-O 2 Ϫ spin adducts. SOD from bovine erythrocytes (Sigma Chemical, St. Louis, MO, U.S.A.) was used as a standard.
Catalase Activity Catalase activity was assayed according to the method described by Aebi. 15) In brief, the striatum was homogenized with 20 volumes of ice-cold RIPA buffer [0.1 M phosphate buffer (pH 7.4) containing 5 mM EDTA, 0.01% digitonin, and 0.25% sodium cholate] and centrifuged at 10000ϫg for 30 min at 4°C. Phosphate buffer (50 mM, pH 7.0) containing EDTA (5 mM) and H 2 O 2 (10 mM) preincubated for 10 min at 37°C was added to the supernatant, and the decomposition of H 2 O 2 was assayed directly by measuring the decrease in absorbance at 240 nm for 2 min. Catalase from bovine liver (Wako Pure Chemical, Osaka, Japan) was used as a standard.
GPx Activity GPx activity was assayed using a Bioxytech GPx-340 kit (OXIS International, Portland, OR, U.S.A.). The striatum was homogenized with 10 volumes of ice-cold 50 mM Tris-HCl buffer (pH 7.5) containing 5 mM EDTA and 1 mM 2-mercaptoethanol, and centrifuged at 10000ϫg for 10 min at 4°C. Supernatant or serum was used for the analysis. GPx from bovine erythrocytes (Sigma, St. Louis, MO, U.S.A.) was used as a standard.
TBARS Levels The concentration of TBARS was measured according to the method described by Buege and Aust 16) with a slight modification. In brief, tissues were homogenized with 20 volumes of ice cold Tris-HCl buffer (20 mM, pH 7.4) containing 2 mM EDTA. Five hundred microliters of TBA reagent (0.375% thiobarbituric acid, 15% trichloroacetic acid, 0.25 N HCl, 0.1 mM EDTA) were added to 250 ml of homogenate and the mixture was heated at 100°C for 15 min. The reaction was terminated by placing the sample into ice-cold water for 10 min. Finally, the sample was centrifuged at 10000ϫg for 10 min, and its absorbance was measured at 535 nm. Malonaldehyde was used as a standard.
Lipid Peroxidation Susceptibility Each striatum was homogenized in 10 volumes of ice-cold Tris-HCl buffer (20 mM, pH 7.4). After ferric chloride in Tris-HCl buffer solution (20 ml, final concentrations: 5 mM) was added to the homogenate (200 ml), the mixture was incubated at 37°C for 20 min to induce oxidation. · OH was generated by a Fentonlike reaction. Lipid peroxides produced were monitored by measuring the concentration of TBARS.
GSH and Asc Determination Striatal tissues were homogenized with 10 volumes of ice-cold 5% metaphosphate containing 20 mM deferoxamine mesylate. After centrifugation (10000ϫg for 10 min at 4°C), the supernatant was diluted tenfold and filtered (pore size, 0.45 mm) and then injected directly into a HPLC (Shimadzu, Kyoto, Japan) with an electrochemical detector (ECD; Eicom, Kyoto, Japan). The appendant potential of the ECD (gold electrode vs. Ag/AgCl reference electrode) was set at 600 mV. The analytic column was TSKgel Super-ODS (4.6 mm I.D.ϫ 100 mm; Tosoh, Tokyo, Japan), and the mobile phase consisted of 0.1 M phosphate buffer (pH 2.5) containing methanol (1%, v/v), disodium EDTA (5 mg/l), and sodium octanesulfonate (400 mg/l).
Protein Level The protein assay was performed by the method of Lowry et al. 17) using bovine serum albumin as standard.
Chemicals All chemicals and reagents were of the highest quality available and obtained either from Wako Pure Chemical Industries (Osaka, Japan) or Sigma (St. Louis, MO, U.S.A.).
Statistical Analysis All data are expressed as the meanϮS.D. Differences between groups were examined for statistical significance using one-way analysis of variance. If F values showed significance, the Scheffe's F test was used to compare groups. A p value less than 0.05 was considered to indicate statistical significance.
RESULTS
Effect of Eugenol on Oxidation of Mouse Brain
Homogenate in Vitro TBARS were determined after incubation of mouse brain homogenates with ferric ion for 20 min at 37°C in the presence of eugenol, at concentrations from 0 to 1000 mM. The concentrations between 0 to 1 mM did not reduce lipid peroxidation in mouse brain homogenate in terms of blunting the increase in TBARS. Only higher concentrations of eugenol (10 to 1000 mM) suppressed oxidation significantly (Fig. 1, left panel) .
Effect of Eugenol on SOD-Like Activity of Supernatant of Mouse Brain
Homogenate in Vitro SOD-like activity of the supernatant was determined in the presence of eugenol at concentrations from 0 to 1000 mM. None of these concentrations reduced SOD-like activity in mouse brain supernatant (Fig. 1, right panel) .
Effect of Eugenol Administration for 3 d before and 7 More Days Following 6-OHDA Injection on the Levels of DA, DOPAC, and HVA in Mouse Striatum
The mean tissue concentrations of DA and its metabolites (DOPAC and HVA) in the mouse striatum are shown in Fig. 2 . DA, DOPAC, and HVA were significantly decreased by 6-OHDA injection compared with the levels in the control striatum. Eugenol treatment blunted the 6-OHDA-induced DA, DOPAC and HVA reduction in a dose-dependent manner. DA recovered to control levels when 1.0 mmol/kg of eugenol was injected once daily for 3 d before and 7 d after 6-OHDA injection. Eugenol alone had no effect on the levels of striatal DA or its metabolites at this time point.
Effect of Eugenol Administration for 3 d before and 7 More Days Following One icv 6-OHDA Injection on the Levels of TBARS (an Index of Lipid Peroxide) in Mouse Striatum
The mean tissue concentrations of TBARS in the mouse striatum are shown in Fig. 3 . The level of TBARS was significantly increased by 6-OHDA injection compared with that in the control striatum. Eugenol treatment inhibited the 6-OHDA-induced TBARS increase. Eugenol alone had no effect on the striatal TBARS level.
Effect of Eugenol Administration for 3 d on the Activities of SOSA, Catalase and GPx in Mouse Striatum
The meanϮS.D. of SOSA, catalase activity, and GPx activity in the mouse striatum 30 min after the last eugenol administration are shown in Table 1 . No significant changes in SOSA, catalase, or GPx activity were induced in the striatum by eugenol administration. However, SOSA had a tendency to increase in a dose-dependent manner. D. (nϭ5) . Significance was determined using one-way ANOVA followed by Sheffe's F test, and * indicates that p was Ͻ0.05 compared with control. Mouse Striatum The mean tissue concentrations of TBARS in the mouse striatum are shown in Fig. 4 . No significant change was induced in the striatum by eugenol administration (left panel). However, the treatment prevented the increase of TBARS after incubation with ferric ion in a dosedependent manner (right panel).
Effect of Eugenol Administration for 3 d on the Level of TBARS and Lipid Peroxidation Susceptibility in
Effect of Eugenol Administration for 3 d on the Levels of GSH and Asc in Mouse Striatum
The mean tissue concentrations of GSH (left panel) and Asc (right panel) in the mouse striatum are shown in Fig. 5 . Eugenol treatment increased the levels of GSH and Asc in a dose-dependent manner.
DISCUSSION
Increased oxidative stress, a decrease of endogenous antioxidants such as GSH, and decreased activities of free radical-scavenging enzymes such as GPx and catalase have been reported in the brains of patients with PD. [18] [19] [20] [21] Accordingly, free radicals and oxidative stress are thought to be important contributors to the pathogenesis of PD.
22) The toxin 6-OHDA has been used to develop parkinsonian models, and the mouse model used here is considered to be an excellent one.
2) Endogenously produced 6-OHDA 3) is thought to act via oxidative mechanisms.
Various antioxidants can prevent 6-OHDA-induced neurotoxicity. 8, 9, 23) Eugenol is an essential oil constituent extracted from cloves and used as a food flavouring agent, and was reported to have antioxidant activity. [10] [11] [12] In this study, we examined the effect of eugenol against 6-OHDA neurotoxicity by measuring decreases of DA, DOPAC, and HVA as markers of dopaminergic neuronal injury. Treatment with eugenol (for 3 d before and 7 d after 6-OHDA injection) inhibited 6-OHDA-induced neurotoxicity, blunting the reductions of striatal tissue DA and its metabolites. Eugenol is reported to be a MAO inhibitor. 13) Its K i value against MAO-B is 221 mM. The amount of eugenol we injected into mice (1.0 mmol/kg daily) was not sufficient to inhibit DA metabolisms. Therefore, the levels of DA, DOPAC, and HVA were not affected by eugenol only injection. It also inhibited the 6-OHDA-induced increase of TBARS (an indicator of lipid peroxidation). These results suggest that eugenol protects dopaminergic neurons by inhibiting lipid peroxidation. However, our in vitro results showed that the amount of eugenol injected into mice was not sufficient to directly inhibit lipid peroxidation. Therefore, we think that eugenol might enhance endogenous antioxidant mechanisms of the mouse. As 6-OHDA is susceptible to auto-oxidation, resulting in the formation of 6-OHDA qui- , and · OH, 4-7) the antioxidative condition of the striatum at the time 6-OHDA was injected was important. Therefore, we measured the effect of eugenol (3 d, administration) on the activities of active oxygen-scavenging enzymes, such as catalase and GPx, in striatum. Catalase and GPx convert H 2 O 2 to H 2 O. Eugenol injection did not influence activities of these enzymes in the striatum. These results indicate that eugenol does not increase the activities of H 2 O 2 -scavenging enzymes. We also measured the effect of eugenol on SOSA in the striatum using ESR spectrometry. SOSA includes all · O 2 Ϫ scavenging activities, including that of SOD and those of other substances. Eugenol injection did not significantly change SOSA in the striatum according to statistical analysis. Although the effect was not significant, the mean value of SOSA tended to increase in a dose-dependent manner in response to eugenol injection.
We next measured endogenous antioxidants such as GSH and Asc. Eugenol injection increased GSH and Asc in a dose-dependent manner. The increases of GSH (0.1 and 1.0 mmol/kg eugenol-injected groups) and Asc (1.0 mmol/kg eugenol-injected group) were significant. GSH is an antioxidant itself and a substrate of GPx. It plays a very important role in reducing lipid peroxide. 6-OHDA is known to produce active oxygen species 4, 5) and also p-quinone during auto-oxidation. 6, 7) p-Quinone induced cell death by decreasing the activities of mitochondrial complex I and IV. 24, 25) Izumi et al. reported that GSH conjugates with p-quinone and protects cell from 6-OHDA toxicity. 26) Increased GSH may protect dopaminergic neuron from 6-OHDA neurotoxicity by conjugating with p-quinone. Asc is a common watersoluble antioxidant in various organisms and rodents can synthesize it, though humans cannot. Iron ions generate oxidant species such as · OH through a series of reactions called the modified Haber-Weiss or Fenton reaction. 27) Incubation of brain homogenate with iron ions induces lipid peroxidation and increases the TBARS level. 28) Eugenol administration for 3 d did not change the TBARS level in the striatum. However, after incubation with iron ions, the TBARS level of the eugenol-treated mouse striatum homogenate was lower than that of the control. This result shows that lipid peroxidation susceptibility was decreased by eugenol treatment. The increases of GSH and Asc may decrease the susceptibility to lipid peroxidation induced by free radical exposure.
Increases of GSH, Asc, and, to a lesser extent, eugenol itself, together may enhance anti-oxidative stress activity and protect dopaminergic neurons against 6-OHDA toxicity in the mouse striatum.
